Bone Substitutes Market Size to Reach USD 5.15 Billion Globally with Growing CAGR of 7% by 2029

According to the CDC report, the global incidence rate of hip fracture is expected to rise by 240% in women and 310% in men. It is estimated that 200 million women worldwide suffer from osteoporosis. Bone disorders are common in the elderly population due to low bone density. The number of Americans aged 65 and older is estimated to be around 46 million in 2016, rising to 98 million by 2060. Rising incidences of musculoskeletal disorders and an ageing population are certain factors that will bring a new innovation in the bone substitutes market.

Data Bridge Market Research analyses that the bone substitutes market which was USD 3 billion in 2021, is expected to reach USD 5.15 billion by 2029, at a CAGR of 7% during the forecast period 2022 to 2029

Market Overview
A bone graft is an implantable material used to promote bone formation, bone healing, osseous reconstruction, and other procedures. These bone graft materials are used in bone grafting surgical procedures to replace defective or missing bone with these materials (bone graft). Although bone replacement had been practiced with various natural materials, it was rarely successful until the late nineteenth century. These substitutes can be derived from biological products such as demineralized bone matrix, platelet-rich plasma, hydroxyapatite, growth factor adjunction (such as bone morphogenetic protein), or synthetic products such as calcium sulphate, tricalcium phosphate ceramics, bioactive glasses, or polymer-based substitutes. All of these substitutes are not appropriate for every clinical application, and they must be chosen carefully based on their intended use.

Key players operating in the global Bone Substitutes include:
• Zimmer Biomet (U.S.)
• Bioventus (U.S.)
• Synergy Orthopedics (U.S.)
• Ito Co., Ltd. (Japan)
• Boston Scientific Corporation (U.S.)
• BTL (Canada)
• Cyberonics, Inc. (U.S.)
• DJO LLC (U.S.)
• Medtronic (Ireland)
• Nevro Corp (U.S.)
• NeuroMetrix, Inc (U.S.)
• Abbott (U.S.)
• Uroplasty Inc (U.S.)
• Cogentix Medical (U.S.)
• Aleva Neurotherapeutics (Switzerland)

Global Bone Substitutes Scope

The Global bone substitutes market is segmented on the basis of product, end user, and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Browse More About This Research Report @

https://www.databridgemarketresearch.com/reports/global-bone-substitutes-market

Browse Trending Reports:
https://dishapatil21.blogspot.com/2023/06/wearable-devices-market.html

https://dishapatil21.blogspot.com/2023/06/antiparasitics-drugs-market.html

https://dishapatil21.blogspot.com/2023/06/asia-pacific-infection-control-market.html

About Data Bridge Market Research:
An absolute way to predict the future is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.

Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: - sopan.gedam@databridgemarketresearch.com

This release was published on openPR.